- Home
- AQST vs NTHI Comparison
AQST vs NTHI Comparison
Compare AQST & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- NTHI
- Stock Information
- Founded
- AQST 2004
- NTHI 2008
- Country
- AQST United States
- NTHI United States
- Employees
- AQST N/A
- NTHI N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- NTHI Biotechnology: Pharmaceutical Preparations
- Sector
- AQST Health Care
- NTHI Health Care
- Exchange
- AQST Nasdaq
- NTHI Nasdaq
- Market Cap
- AQST 254.1M
- NTHI 225.0M
- IPO Year
- AQST 2018
- NTHI N/A
- Fundamental
- Price
- AQST $2.51
- NTHI $6.95
- Analyst Decision
- AQST Strong Buy
- NTHI
- Analyst Count
- AQST 6
- NTHI 0
- Target Price
- AQST $11.17
- NTHI N/A
- AVG Volume (30 Days)
- AQST 1.4M
- NTHI 59.9K
- Earning Date
- AQST 05-06-2025
- NTHI 01-01-0001
- Dividend Yield
- AQST N/A
- NTHI N/A
- EPS Growth
- AQST N/A
- NTHI N/A
- EPS
- AQST N/A
- NTHI N/A
- Revenue
- AQST $57,561,000.00
- NTHI $83,000.00
- Revenue This Year
- AQST N/A
- NTHI N/A
- Revenue Next Year
- AQST $39.51
- NTHI N/A
- P/E Ratio
- AQST N/A
- NTHI N/A
- Revenue Growth
- AQST 13.79
- NTHI N/A
- 52 Week Low
- AQST $2.20
- NTHI $6.10
- 52 Week High
- AQST $5.80
- NTHI $25.00
- Technical
- Relative Strength Index (RSI)
- AQST 41.88
- NTHI N/A
- Support Level
- AQST $2.20
- NTHI N/A
- Resistance Level
- AQST $2.61
- NTHI N/A
- Average True Range (ATR)
- AQST 0.22
- NTHI 0.00
- MACD
- AQST -0.03
- NTHI 0.00
- Stochastic Oscillator
- AQST 36.47
- NTHI 0.00
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.